Literature DB >> 28649992

A Key Role for Neurotensin in Chronic-Stress-Induced Anxiety-Like Behavior in Rats.

Catherine P Normandeau1,2, Ana Paula Ventura-Silva3,4, Emily R Hawken1,2, Staci Angelis1,2, Calvin Sjaarda5, Xudong Liu5, José Miguel Pêgo3,4, É C Dumont1,2.   

Abstract

Chronic stress is a major cause of anxiety disorders that can be reliably modeled preclinically, providing insight into alternative therapeutic targets for this mental health illness. Neuropeptides have been targeted in the past to no avail possibly due to our lack of understanding of their role in pathological models. In this study we use a rat model of chronic stress-induced anxiety-like behaviors and hypothesized that neuropeptidergic modulation of synaptic transmission would be altered in the bed nucleus of the stria terminalis (BNST), a brain region suspected to contribute to anxiety disorders. We use brain slice neurophysiology and behavioral pharmacology to compare the role of locally released endogenous neuropeptides on synaptic transmission in the oval (ov) BNST of non-stressed (NS) or chronic unpredictably stressed (CUS) rats. We found that in NS rats, post-synaptic depolarization induced the release of vesicular neurotensin (NT) and corticotropin-releasing factor (CRF) that co-acted to increase ovBNST inhibitory synaptic transmission in 59% of recorded neurons. CUS bolstered this potentiation (100% of recorded neurons) through an enhanced contribution of NT over CRF. In contrast, locally released opioid neuropeptides decreased ovBNST excitatory synaptic transmission in all recorded neurons, regardless of stress. Consistent with CUS-induced enhanced modulatory effects of NT, blockade of ovBNST NT receptors completely abolished stress-induced anxiety-like behaviors in the elevated plus maze paradigm. The role of NT has been largely unexplored in stress and our findings highlight its potential contribution to an important behavioral consequence of chronic stress, that is, exaggerated avoidance of open space in rats.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28649992      PMCID: PMC5729557          DOI: 10.1038/npp.2017.134

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  53 in total

1.  Differential expression of intrinsic membrane currents in defined cell types of the anterolateral bed nucleus of the stria terminalis.

Authors:  Sayamwong E Hammack; Irakli Mania; Donald G Rainnie
Journal:  J Neurophysiol       Date:  2007-05-30       Impact factor: 2.714

2.  Studies on the cellular architecture of the bed nuclei of the stria terminalis in the rat: II. Chemoarchitecture.

Authors:  G Ju; L W Swanson; R B Simerly
Journal:  J Comp Neurol       Date:  1989-02-22       Impact factor: 3.215

Review 3.  Brain neurotensin, psychostimulants, and stress--emphasis on neuroanatomical substrates.

Authors:  Stefanie Geisler; Anne Bérod; Daniel S Zahm; William Rostène
Journal:  Peptides       Date:  2006-08-24       Impact factor: 3.750

4.  Regulation of bed nucleus of the stria terminalis PACAP expression by stress and corticosterone.

Authors:  Kimberly R Lezak; Carolyn W Roman; Karen M Braas; Kristin C Schutz; William A Falls; Jay Schulkin; Victor May; Sayamwong E Hammack
Journal:  J Mol Neurosci       Date:  2014-03-12       Impact factor: 3.444

5.  Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis.

Authors:  Thomas L Kash; Danny G Winder
Journal:  Neuropharmacology       Date:  2006-08-10       Impact factor: 5.250

6.  Noradrenaline triggers GABAA inhibition of bed nucleus of the stria terminalis neurons projecting to the ventral tegmental area.

Authors:  Eric C Dumont; John T Williams
Journal:  J Neurosci       Date:  2004-09-22       Impact factor: 6.167

7.  Acute reversible inactivation of the bed nucleus of stria terminalis induces antidepressant-like effect in the rat forced swimming test.

Authors:  Carlos C Crestani; Fernando H F Alves; Fernando M A Correa; Francisco S Guimarães; Sâmia R L Joca
Journal:  Behav Brain Funct       Date:  2010-06-01       Impact factor: 3.759

8.  Neuroanatomical characterization of endogenous opioids in the bed nucleus of the stria terminalis.

Authors:  Jean-François Poulin; Danielle Arbour; Sylvie Laforest; Guy Drolet
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-07-04       Impact factor: 5.067

9.  alpha2A-adrenergic receptors heterosynaptically regulate glutamatergic transmission in the bed nucleus of the stria terminalis.

Authors:  A D Shields; Q Wang; D G Winder
Journal:  Neuroscience       Date:  2009-06-12       Impact factor: 3.590

10.  Neural control of chronic stress adaptation.

Authors:  James P Herman
Journal:  Front Behav Neurosci       Date:  2013-08-08       Impact factor: 3.558

View more
  19 in total

1.  A Corticotropin Releasing Factor Network in the Extended Amygdala for Anxiety.

Authors:  Matthew B Pomrenze; Jorge Tovar-Diaz; Angelo Blasio; Rajani Maiya; Simone M Giovanetti; Kelly Lei; Hitoshi Morikawa; F Woodward Hopf; Robert O Messing
Journal:  J Neurosci       Date:  2018-12-10       Impact factor: 6.167

2.  Diverse actions of the modulatory peptide neurotensin on central synaptic transmission.

Authors:  Christopher W Tschumi; Michael J Beckstead
Journal:  Eur J Neurosci       Date:  2018-02-28       Impact factor: 3.386

3.  Comprehensive Identification and Spatial Mapping of Habenular Neuronal Types Using Single-Cell RNA-Seq.

Authors:  Shristi Pandey; Karthik Shekhar; Aviv Regev; Alexander F Schier
Journal:  Curr Biol       Date:  2018-03-22       Impact factor: 10.834

Review 4.  Neurotensin in reward processes.

Authors:  María Luisa Torruella-Suárez; Zoe A McElligott
Journal:  Neuropharmacology       Date:  2020-02-11       Impact factor: 5.250

5.  Chronic stress induces cell type-selective transcriptomic and electrophysiological changes in the bed nucleus of the stria terminalis.

Authors:  Sarah E Daniel; Aurélie Menigoz; Jidong Guo; Steven J Ryan; Shivani Seth; Donald G Rainnie
Journal:  Neuropharmacology       Date:  2019-03-14       Impact factor: 5.250

6.  Neurotensin Release from Dopamine Neurons Drives Long-Term Depression of Substantia Nigra Dopamine Signaling.

Authors:  Christopher W Tschumi; Harris E Blankenship; Ramaswamy Sharma; William B Lynch; Michael J Beckstead
Journal:  J Neurosci       Date:  2022-07-06       Impact factor: 6.709

7.  A novel GPR55-mediated satiety signal in the oval Bed Nucleus of the Stria Terminalis.

Authors:  E R Hawken; C P Normandeau; J Gardner Gregory; B Cécyre; J-F Bouchard; K Mackie; É C Dumont
Journal:  Neuropsychopharmacology       Date:  2019-01-07       Impact factor: 7.853

8.  Neurotensin and dynorphin Bi-Directionally modulate CeA inhibition of oval BNST neurons in male mice.

Authors:  C P Normandeau; M L Torruella Suárez; P Sarret; Z A McElligott; E C Dumont
Journal:  Neuropharmacology       Date:  2018-09-21       Impact factor: 5.250

9.  Dissecting the Roles of GABA and Neuropeptides from Rat Central Amygdala CRF Neurons in Anxiety and Fear Learning.

Authors:  Matthew B Pomrenze; Simone M Giovanetti; Rajani Maiya; Adam G Gordon; Lauren J Kreeger; Robert O Messing
Journal:  Cell Rep       Date:  2019-10-01       Impact factor: 9.423

10.  Gender Related Changes in Gene Expression Induced by Valproic Acid in A Mouse Model of Autism and the Correction by S-adenosyl Methionine. Does It Explain the Gender Differences in Autistic Like Behavior?

Authors:  Liza Weinstein-Fudim; Zivanit Ergaz; Gadi Turgeman; Joseph Yanai; Moshe Szyf; Asher Ornoy
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.